Business
Press Release Sep 12 2022
Zydus Lifesciences Limited has informed the Exchange about press release dated 12-Sep-2022 titled Zydus receives final approval and 180 days shared exclusivity from the USFDA for Cariprazine Capsules
About this update from Zydus Lifesciences Limited
[{"type":"text","content":" Zydus Lifesciences Limited has informed the Exchange about press release dated 12-Sep-2022 titled Zydus receives final approval and 180 days shared exclusivity from the USFDA for Cariprazine Capsules View Attachment","length":353,"tagName":"div"}]